Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples